In a study of men on active surveillance for low-risk prostate cancer, multiparametric magnetic resonance imaging by itself missed about one-fifth of men who had pathologic upgrading on subsequent biopsies.
Combining PSA density with prostate MRI findings improves the predictive performance of PI-RADS in men without a prior prostate cancer diagnosis.
Use of a gonadotropin-releasing hormone antagonist is associated with lower risks for death than GnRH agonists, a systematic review and meta-analysis found.
A new analysis looking at the effect of PSA screening on prostate cancer mortality over a 25-year period found a more favorable balance of benefits and harms than the 16-year estimates from the European Randomized Study of Screening for Prostate Cancer.
Three major medical organizations have issued recommendations for the diagnosis and treatment of advanced prostate cancer, including metastatic hormone-sensitive disease and nonmetastatic and metastatic castration-resistant disease.
In a study, a higher 4Kscore was significantly associated with a 16% greater risk of biochemical recurrence of prostate cancer following radical prostatectomy.
Injection of a hydrogel spacer to provide prostate-rectum separation during radiation therapy for prostate cancer is associated with decreased radiation-induced rectal toxic effects, according to a new systematic review and meta-analysis.
A population-based Italian study found that among men with prostate cancer, those not receiving androgen deprivation therapy had significant 4-fold increased odds of testing positive for SARS-CoV-2 than those receiving ADT.
New recommendations from an international consensus conference call for genetic testing of all men with metastatic prostate cancer (PCa) and those with a family history indicative of hereditary PCa and suggest strategies for genetic evaluation.
Since 1990, proportion of white participants in prostate cancer clinical trials has remained >80%.
